Literature DB >> 9669214

Abolition of anaphylactic shock by Solanum lyratum Thunb.

B Kang1, E Lee, I Hong, J Lee, H Kim.   

Abstract

We investigated the effects of the aqueous extract of Solanum lyratum THUNB. (Solanaceae) (SLAE) on the anaphylactic reactions. SLAE inhibited compound 48/80-induced anaphylactic shock 100% with a dose of 1.0 mg/g body weight (BW). When SLAE was pretreated at concentration ranging from 0.0001-1.0 mg/g BW, the serum histamine levels were reduced in a dose-dependent manner. Passive cutaneous anaphylaxis also inhibited to 69.3% by oral administration of SLAE (0.05 mg/g BW). Moreover, SLAE dose-dependently inhibited the histamine release from the rat peritoneal mast cells (RPMC) by compound 48/80. The level of cAMP in RPMC, when SLAE was added, significantly increased compared with that of normal control. These results indicate that SLAE possess strong antianaphylactic activity.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9669214     DOI: 10.1016/s0192-0561(97)00035-0

Source DB:  PubMed          Journal:  Int J Immunopharmacol        ISSN: 0192-0561


  2 in total

1.  Solanum lyratum Extracts Induce Extrinsic and Intrinsic Pathways of Apoptosis in WEHI-3 Murine Leukemia Cells and Inhibit Allograft Tumor.

Authors:  Jai-Sing Yang; Chia-Chun Wu; Chao-Lin Kuo; Yu-Hsuan Lan; Chin-Chung Yeh; Chien-Chih Yu; Jin-Cherng Lien; Yuan-Man Hsu; Wei-Wen Kuo; W Gibson Wood; Minoru Tsuzuki; Jing-Gung Chung
Journal:  Evid Based Complement Alternat Med       Date:  2012-05-07       Impact factor: 2.629

2.  Comparative pharmacokinetics of chlorogenic acid after oral administration in rats.

Authors:  Wei Qi; Ting Zhao; Wen-Wen Yang; Guang-Hou Wang; Hua Yu; Hai-Xiao Zhao; Chen Yang; Li-Xin Sun
Journal:  J Pharm Anal       Date:  2011-11-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.